Cover Image

Information on the decisions of foreign regulatory authorities

Show other versions (2)

Saved in:

Bibliographic Details
Main Authors:	T. M. Bukatina (Author), E. Yu. Pasternak (Author), B. K. Romanov (Author), R. N. Alyautdin (Author), V. K. Lepakhin (Author), A. S. Kazakov (Author), K. E. Zatolochina (Author), I. I. Snegireva (Author), M. A. Darmostukova (Author), E. Yu. Kolesnikova (Author), E. O. Zhuravleva (Author), N. Yu. Velts (Author), G. V. Kutekhova (Author)
Format:	Book
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2018-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Information on the decisions of foreign regulatory authorities
by: T. M. Bukatina, et al.
Published: (2018)

Information on the decisions of foreign regulatory authorities
by: T. M. Bukatina, et al.
Published: (2018)

Analysis of the decisions of foreign regulatory authorities
by: T. M. Bukatina, et al.
Published: (2018)

Analysis of the decisions of foreign regulatory authorities
by: T. M. Bukatina, et al.
Published: (2018)

Foreign regulatory recommendations
by: T. M. Bukatina, et al.
Published: (2018)

POST-MARKETING DRUG SAFETY RESEARCH: ANALYSIS OF RECOMMENDATIONS OF FOREIGN REGULATORS
by: E. V. Shubnikova, et al.
Published: (2018)

Modern approaches to collecting and reporting information on side effects
by: K. E. Zatolochina, et al.
Published: (2018)

Monitoring Drug Safety Information - Recommendations of Foreign Regulatory Authorities
by: Elena V. Shubnikova, et al.
Published: (2020)

MYOPATHY CAUSED BY THE INTERACTION OF COLCHICINE AND STATINS
by: A. S. Kazakov, et al.
Published: (2018)

On the interchangeability of calcineurine inhibitors
by: K. E. Zatolochina, et al.
Published: (2018)

Inhibitors of sodium-glucose cotransporter 2: risk of ketoacidosis
by: T. M. Bukatina, et al.
Published: (2018)

The risk of an acute attack of angle-closure glaucoma during the treatment with modern antidepressant drugs
by: T. V. Romanova, et al.
Published: (2018)

Ketoacidosis as unexpected adverse reaction SGLT<sub>2</sub> inhibitor
by: T. M. Bukatina, et al.
Published: (2018)

On improving the safety of new direct acting oral anticoagulants
by: N. Yu. Velts, et al.
Published: (2018)

Analysis of spontaneous reports of adverse reactions, developed in the use of drugs during pregnancy
by: E. O. Zhuravleva, et al.
Published: (2018)

The risk management system as the important part of good pharmacovigilance practices (GVP)
by: A. S. Kazakov, et al.
Published: (2018)

UNEXPECTED ADVERSE REACTIONS OF THE DRUGS OF THE GROUP OF INHIBITORS OF DIPEPTIDYL PEPTIDASE-4
by: T. V. Romanova, et al.
Published: (2018)

Signal Messages in Pediatric Practice
by: G. V. Kutekhova, et al.
Published: (2018)

Problems of interchangeability of systemic interferons for treatment of multiple sclerosis
by: I. I. Snegireva, et al.
Published: (2018)

International Drug Safety Monitoring
by: A. S. Kazakov, et al.
Published: (2019)

Interferon Beta: Analysis of Information on Adverse Reactions and Evaluation of Possibility of Signal Identification
by: K. E. Zatolochina, et al.
Published: (2019)

Statistical signal detection methods
by: K. E. Zatolochina, et al.
Published: (2018)

Social media as a source of information on drug safety and how to extract it
by: I. I. Snegireva, et al.
Published: (2018)

The Adverse Drug Reactions Registered During the Postmarketing Period
by: E. V. Shubnikova, et al.
Published: (2019)

SIGNAL AS A TOOL OF THE PHARMACOVIGILANCE
by: E. O. Zhuravleva, et al.
Published: (2018)

Vaccine Safety International Monitoring
by: M. A. Darmostukova, et al.
Published: (2019)

Malaria and safety issues associated with antimalarial drugs
by: A. S. Kazakov, et al.
Published: (2018)

Nanoscale Therapeutic System: Safety Assessment Features
by: E. M. Bovina, et al.
Published: (2019)

Nonsteroidal anti-inflammatory drugs: problems of safe use
by: N. Yu. Velts, et al.
Published: (2018)

ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
by: N. Yu. Velts, et al.
Published: (2018)

The risk of milk thistle (<i>Silybum marianum</i>) drug interactions
by: A. S. Kazakov, et al.
Published: (2018)

Practical recommendations for screening of information on the drug safety
by: E. Yu. Pasternak, et al.
Published: (2018)

Comparative Analysis of International Databases of Adverse Drug Reactions
by: A. S. Kazakov, et al.
Published: (2020)

The rules of good laboratory practice
by: N. Yu. Velts, et al.
Published: (2018)

Safety of apremilast: risk of psychical disorders
by: T. M. Bukatina, et al.
Published: (2018)

Drug-induced liver injuries in pregnancy in the context of polypragmasy
by: N. Yu. Velts, et al.
Published: (2018)

Foreign regulatory recommendations
by: E. Y. Pasternak
Published: (2018)

Expert Evaluation of Pharmacovigilance System Documents Included in the Registration Dossier
by: I. I. Snegireva, et al.
Published: (2020)

Analysis of Noncompliances with Legislative Requirements in Pharmacovigilance Materials of Registration Dossiers
by: E. O. Zhuravleva, et al.
Published: (2021)

Peculiarities of approaches to assessing the interchangeability of antiepileptic drugs
by: E. O. Zhuravleva, et al.
Published: (2018)